Nippon India Pharma Fund vs UTI Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8357 Cr | ₹1119 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 28% |
Expense Ratio | 1.82 | 2.22 |
Manager | Sailesh Raj Bhan | Kamal Gada |
ISIN Code | INF204K01968 | INF789F01695 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | -0.49% | 0.19% |
6 Month | 11.41% | 15.59% |
1 Year | -2.1% | 2.08% |
3 Year | 23.18% | 25.89% |
5 Year | 18.41% | 18.55% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 2.85% | 5.59% |
1 Year | 8% | 13.89% |
3 Year | 21.14% | 26.3% |
5 Year | 18.27% | 20.61% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 17.31% | 12.22% |
3 Year | 20.52% | 16.31% |
5 Year | 20.64% | 14.54% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 15.03% | 15.66% |
Sharp | 1.00% | 1.09% |
Beta | 0.91% | 0.95% |
Alpha | 0.32% | 1.61% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Sailesh Raj Bhan | Kamal Gada |
Total AUM | ₹96086 Cr | ₹870 Cr |
Funds Managed | 5 | 1 |
Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 1.47 | 5.33 |
Large Cap | 34.68 | 23.12 |
Mid Cap | 32.06 | 31.48 |
Small Cap | 31.79 | 40.07 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 0.55 | 2.34 |
Healthcare | 99.45 | 96.62 |
Basic Materials | - | 1.03 |
Top Comparisons
Aditya Birla Sun Life Arbitrage Fund - Regular Plan - Growth
3Y Returns6.93%
LIC MF Arbitrage Fund Regular - Growth
3Y Returns6.58%
SBI Floating Rate Debt Fund - Regular Plan - Growth
3Y Returns7.6%
Aditya Birla Sun Life Floating Rate Fund-Regular Plan-Growth
3Y Returns7.62%
Nippon India Large Cap Fund- Growth Plan Bonus Option
3Y Returns18.29%
Aditya Birla Sun Life Large Cap Fund-Growth
3Y Returns14.57%
DSP Regular Savings Fund- Regular Plan - Growth
3Y Returns9.84%
Axis Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns6.81%